review · Current Pharmaceutical Design · 2002
The Promise of Structural Genomics in the Discovery of New Antimicrobial Agents
Sean G. Buchanan, J.M. Sauder, Tess Harris
Cited by 12Abstract and details only
Abstract
Structural Genomics stands out among the emerging fields of proteomics since it influences the drug discovery process at so many points. Recent developments in protein expression technologies, x-ray crystallography and NMR spectroscopy provide the essential elements for high-throughput structure determination platforms. Bioinformatics methods to interrogate the resulting data will provide comprehensive, genome-wide databases of protein structure. Genomic sequencing and methods for high-throughput expression and protein purification are furthest advanced for microbial genes and so these have been the early targets for structural genomics initiatives. The information will be invaluable in understanding gene function, designing broad-spectrum small molecule inhibitors and in better understanding drug-host interactions.
Cite this paper
Buchanan, S. G., Sauder, J., & Harris, T. (2002). The Promise of Structural Genomics in the Discovery of New Antimicrobial Agents. Current Pharmaceutical Design, 8(13), 1173–1188. https://doi.org/10.2174/1381612023394809
Buchanan, Sean G., et al. “The Promise of Structural Genomics in the Discovery of New Antimicrobial Agents.” Current Pharmaceutical Design, vol. 8, no. 13, 2002, pp. 1173–88, https://doi.org/10.2174/1381612023394809.
Buchanan, Sean G., J.M. Sauder, and Tess Harris. 2002. “The Promise of Structural Genomics in the Discovery of New Antimicrobial Agents.” Current Pharmaceutical Design 8 (13): 1173–88. https://doi.org/10.2174/1381612023394809.
Buchanan, S.G., Sauder, J. and Harris, T. (2002) ‘The Promise of Structural Genomics in the Discovery of New Antimicrobial Agents’, Current Pharmaceutical Design, 8(13), pp. 1173–1188. Available at: https://doi.org/10.2174/1381612023394809.
@article{buchanan2002promise,
title = {{The Promise of Structural Genomics in the Discovery of New Antimicrobial Agents}},
author = {Buchanan, Sean G. and Sauder, J.M. and Harris, Tess},
journal = {Current Pharmaceutical Design},
volume = {8},
number = {13},
pages = {1173--1188},
year = {2002},
doi = {10.2174/1381612023394809}
}Made from the index record. Check names, capitalisation and page numbers against the paper. Need another style? AI for Research has over 10,000.
Related papers
The success of structural genomics
Thomas C. Terwilliger · Journal of Structural and Functional Genomics · 2011
Cited by 21Open access
Structural Genomics and Nuclear Magnetic Resonance
Dong Liu, Jinfeng Wang · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · 2001
Cited by 0
Structural genomics projects in Japan.
Shigeyuki Yokoyama, Hiroshi Hirota, T. Kigawa et al. · Nature Structural Biology · 2000
Cited by 342
The Advancement of Plant Functional Genomics Research
Yong Zhang · 河西学院学报 · 2005
Cited by 0
Can Small Laboratories Do Structural Genomics?
Ronny C. Hughes, Joseph D. Ng · Crystal Growth & Design · 2007
Cited by 9
Study and Progress in Functional Genomics in Plants
BU Qing-mei · Journal of Yantai College of Education · 2005
Cited by 0
Structural proteomics by NMR spectroscopy
Joon‐Han Shin, Woonghee Lee, Weontae Lee · Expert Review of Proteomics · 2008
Cited by 56
Functional genomics: tools of the trade
Gillian Colebatch, Ben Trevaskis, Michael K. Udvardi · New Phytologist · 2002
Cited by 44Open access